Quality of Life Analyses in a Clinical Trial of DPPE (tesmilifene) Plus Doxorubicin Versus Doxorubicin in Patients with Advanced or Metastatic Breast Cancer: NCIC CTG Trial MA.19

被引：0
|
作者：
Jianhua Liu
Dongsheng Tu
Janet Dancey
Leonard Reyno
Kathleen I. Pritchard
Joseph Pater
Lesley K Seymour
机构：
[1] Cancer Research Institute,National Cancer Institute of Canada Clinical Trials Group
[2] Queens University,undefined
来源：
Breast Cancer Research and Treatment | 2006年 / 100卷
关键词：
Quality of life; Analyses; Statistical methods; DPPE; Breast cancer; Tesmilifene;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：263 / 271
页数：8
相关论文
共 50 条
  • [21] The efficacy of herbal therapy on quality of life in patients with breast cancer: self-control clinical trial
    Wong, Lai Yi Eliza
    Wong, Chun Kwok
    Leung, Ping Chung
    Lam, Wei Kei Christopher
    PATIENT PREFERENCE AND ADHERENCE, 2010, 4 : 223 - 229
  • [22] Phase Ib dose-finding trial of lapatinib plus pegylated liposomal doxorubicin in advanced HER2-positive breast cancer
    Andrea Rocca
    Lorenzo Cecconetto
    Alessandro Passardi
    Elisabetta Melegari
    Daniele Andreis
    Manuela Monti
    Roberta Maltoni
    Samanta Sarti
    Elisabetta Pietri
    Alessio Schirone
    Francesco Fabbri
    Caterina Donati
    Oriana Nanni
    Anna Fedeli
    Marina Faedi
    Dino Amadori
    Cancer Chemotherapy and Pharmacology, 2017, 79 : 863 - 871
  • [23] Phase Ib dose-finding trial of lapatinib plus pegylated liposomal doxorubicin in advanced HER2-positive breast cancer
    Rocca, Andrea
    Cecconetto, Lorenzo
    Passardi, Alessandro
    Melegari, Elisabetta
    Andreis, Daniele
    Monti, Manuela
    Maltoni, Roberta
    Sarti, Samanta
    Pietri, Elisabetta
    Schirone, Alessio
    Fabbri, Francesco
    Donati, Caterina
    Nanni, Oriana
    Fedeli, Anna
    Faedi, Marina
    Amadori, Dino
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2017, 79 (05) : 863 - 871
  • [24] A randomized trial of eribulin monotherapy versus eribulin plus anlotinib in patients with locally recurrent or metastatic breast cancer
    Liu, B.
    Liu, L.
    Ran, J.
    Xie, N.
    Li, J.
    Xiao, H.
    Yang, X.
    Tian, C.
    Wu, H.
    Lu, J.
    Gao, J.
    Hu, X.
    Cao, M.
    Shui, Z.
    Hu, Z. -y.
    Ouyang, Q.
    ESMO OPEN, 2023, 8 (03)
  • [25] Evaluating health-related quality-of-life therapeutic effectiveness in a clinical trial with extensive nonignorable missing data and heterogeneous response: results from a phase III randomized trial of gemcitabine plus paclitaxel versus paclitaxel monotherapy in patients with metastatic breast cancer
    Carol M. Moinpour
    Gary W. Donaldson
    Astra M. Liepa
    Allen S. Melemed
    Joyce O’Shaughnessy
    Kathy S. Albain
    Quality of Life Research, 2012, 21 : 765 - 775
  • [26] Evaluating health-related quality-of-life therapeutic effectiveness in a clinical trial with extensive nonignorable missing data and heterogeneous response: results from a phase III randomized trial of gemcitabine plus paclitaxel versus paclitaxel monotherapy in patients with metastatic breast cancer
    Moinpour, Carol M.
    Donaldson, Gary W.
    Liepa, Astra M.
    Melemed, Allen S.
    O'Shaughnessy, Joyce
    Albain, Kathy S.
    QUALITY OF LIFE RESEARCH, 2012, 21 (05) : 765 - 775
  • [27] Phase I trial of liposomal encapsulated doxorubicin (Myocet™M; D-99) and weekly docetaxel in advanced breast cancer patients
    Mrózek, E
    Rhoades, CA
    Allen, J
    Hade, EM
    Shapiro, CL
    ANNALS OF ONCOLOGY, 2005, 16 (07) : 1087 - 1093
  • [28] Patient-reported pain and other quality of life domains as prognostic factors for survival in a phase III clinical trial of patients with advanced breast cancer
    Emily Nash Smyth
    Wei Shen
    Lee Bowman
    Patrick Peterson
    William John
    Allen Melemed
    Astra M. Liepa
    Health and Quality of Life Outcomes, 14
  • [29] A multicenter, randomized, open label, two formulation, crossover bioequivalence trial of doxorubicin hydrochloride liposomal injection in Chinese patients with metastatic breast cancer
    Wang, Jingshu
    Lai, Xiuping
    Yao, Herui
    Yang, Hui
    Cao, Xiaolong
    Wang, Xiaochen
    Wang, Ying
    Nian, Weiqi
    Zheng, Xiaodong
    Mai, Qingxiu
    Liu, Anding
    Lv, Xiaozhi
    Bi, Xiaoying
    Chen, Junyi
    Wu, Junyan
    Ye, Suiwen
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2025, 151 (01)
  • [30] Phase II trial of pegylated liposomal doxorubicin-cyclophosphamide combination as first-line chemotherapy in older metastatic breast cancer patients
    Kurtz, J. E.
    Rousseau, F.
    Meyer, N.
    Delozier, T.
    Serin, D.
    Nabet, M.
    Djafari, L.
    Dufour, P.
    ONCOLOGY, 2007, 73 (3-4) : 210 - 214
12345